Federated Hermes, Inc. 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-10 11:39 am Purchase |
2023-03-31 | 13G | Orchard Therapeutics plc ORTX |
FEDERATED HERMES INC. FHI |
840,169 4.570% |
0 (+0.00%) |
Filing |
| 2023-02-01 11:25 am Purchase |
2022-12-31 | 13G | Orchard Therapeutics plc ORTX |
FEDERATED HERMES INC. FHI |
840,169 6.630% |
9,183 (+1.11%) |
Filing |
| 2022-02-14 1:26 pm Purchase |
2021-12-31 | 13G | Orchard Therapeutics plc ORTX |
FEDERATED HERMES INC. FHI |
830,986 6.620% |
830,986 (New Position) |
Filing |